Stephen Colbert, Jimmy Kimmel, and Seth Meyers survey urine and other fake COVID cures, test Ron DeSantis

The COVID-19 pandemic is "bad here in L.A., everybody has it," Jimmy Kimmel said on Monday's Kimmel Live. "COVID is like the new kombucha here." Yet still, "millions of Americans won't get vaccinated," he said, advising President Biden to look to Canada, where Quebec had success by requiring proof of vaccination to enter liquor and cannabis stores. "I think maybe Pfizer needs to come out with some gummies and a hard lemonade," Kimmel deadpanned.

"But of course there are all sorts of new crazy miracle cures and remedies," Kimmel said, focusing on the latest craze, from some "anti-vaxxhole" touting "the benefits of his all-natural COVID killer," urine by the glass. "By the way, if this guy's kids ever set up a lemonade stand in your neighborhood, run," he joked. "You know, there's so much stuff to sell to these anti-vaxxers," he said, showing a fake "Anti-Vax Barbie" ad that veers into dark comedy.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.